Roscovitine (Seliciclib)

For research use only.

Catalog No.S1153 Synonyms: CYC202, R-roscovitine

86 publications

Roscovitine (Seliciclib) Chemical Structure

CAS No. 186692-46-6

Roscovitine (Seliciclib, CYC202, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.

Size Price Stock Quantity  
10mM (1mL in DMSO) EUR 187 In stock
EUR 144 In stock
EUR 252 In stock
EUR 461 In stock
EUR 953 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Roscovitine (Seliciclib) has been cited by 86 publications

Purity & Quality Control

Choose Selective CDK Inhibitors

Biological Activity

Description Roscovitine (Seliciclib, CYC202, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.
Targets
CDK5/p35 [1]
(Cell-free assay)
Cdc2/CyclinB [1]
(Cell-free assay)
CDK2/CyclinA [1]
(Cell-free assay)
CDK2/CyclinE [1]
(Cell-free assay)
ERK2 [1]
(Cell-free assay)
0.16 μM 0.65 μM 0.7 μM 0.7 μM 14 μM
In vitro

Roscovitine displays high efficiency and high selectivity towards some cyclin-dependent kinases with IC50 of 0.65, 0.7, 0.7 and 0.16 μM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p53, respectively. [1] Roscovitine reversibly inhibits the prophaselmetaphase transition in the micromolar range of starfish oocytes and sea urchin embryos, inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg extracts, and suppresses the proliferation of mammalian cell lines with an average IC50 of 16 μM. [1] In mesangial cells, Roscovitine results in a dose-dependent reduction of CDK2 activity that at concentrations of 7.5, 12.5 and 25 mM, Roscovitine causes a 25, 50% and 100% decrease in CDK2 activity, respectively. [2] A recent study shows that Roscovitine inhibits cdk5 kinase activity, cell proliferation, multicellular development, and cdk5 nuclear translocation in Dictyostelium discoideum, without affecting the expression of cdk5 protein during axenic growth. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LB771-HNC MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV7JR|UxRTR6LkmyNVIh|ryP M1;mZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LB2241-RCC M3[wfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEK3cpFKSzVyPUS4MlYzODJizszN NX3XOJRZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
DU-4475 NVr1VnJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXTFNJpZUUN3ME20PE41QTN5IN88US=> MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LB2518-MEL NUHTbXpZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nQO2lEPTB;NEeuNFQ1QCEQvF2= M{f5PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-H209 NV3IPY92T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVHJR|UxRTR4LkCxNVUh|ryP M3yxUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
CGTH-W-1 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWjuWpJ[UUN3ME20OE46Pjl5IN88US=> MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
MS-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDiW4hkUUN3ME20Nk45QTNizszN MnjwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
GI-ME-N M{K1[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFO2cZFKSzVyPUSyMlY3PzFizszN M4\h[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
DG-75 NV6yRWdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjCdllKSzVyPUSyMlY2PDZizszN NUPHUZBvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MLMA NX3N[4RxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWjJR|UxRTR{LkK3PFch|ryP M3z5R|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
HT MmPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3OwN2lEPTB;NEKuNFAzQCEQvF2= NYT6Wld7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
LC-1F M1vhNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTRzLkW3NFUh|ryP MnH4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H1882 M2raNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXqTWM2OD12MD61PVk5KM7:TR?= M3TuclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NTERA-S-cl-D1 M2HRbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHyxcm5KSzVyPUO5MlU5PDJizszN MoPNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H345 NWTKSI1yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37Pe2lEPTB;M{iuPVExPiEQvF2= NIfXbYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MONO-MAC-6 NXHvOJV[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVPJR|UxRTN6LkK0O|ch|ryP MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
RS4-11 NUH4bohET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTN5LkewOlkh|ryP M{DFSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ML-2 NWf6N45JT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnO1TWM2OD1|Nz62O|EzKM7:TR?= M4e0elxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
OPM-2 M4fDNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXPJR|UxRTN5LkK5OFkh|ryP M13DVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LU-139 M3vFN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTN5LkG4OVYh|ryP M{LuN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
COLO-684 NGC3VY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIfZO41KSzVyPUO3MlAyOiEQvF2= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
MOLT-4 Mn7PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTN4LkOyO|Yh|ryP NX;5dodIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-6 NHXSemZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTN4LkOyOFYh|ryP MlS5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
TE-441-T MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHHTWM2OD1|Nj6xNVQ5KM7:TR?= M3rhU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
IMR-5 M3r5OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlrrTWM2OD1|NT6zNVM6KM7:TR?= MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
K5 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2S2dmlEPTB;M{WuNFg3OSEQvF2= M3uwfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
TE-10 M2fSU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXjEfZkzUUN3ME2zOE46PDJ{IN88US=> NHHUNFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H2141 MkDJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvGTWM2OD1|ND62OVM{KM7:TR?= NWrQblViRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KGN NVHWTWg5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTN2LkK1NlQh|ryP MlTaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
LP-1 NVvVRVBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXu3d481UUN3ME2zN{45QTB6IN88US=> NV7vd4FmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H64 M4\GcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjNdY5KSzVyPUOzMlg2QTdizszN MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
RKO NXjyXZkxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1fk[GlEPTB;M{OuOVk3QSEQvF2= NFfHOYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H526 M3z0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3rDcGlEPTB;M{OuOFk{PiEQvF2= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
GOTO NF7YNlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHTPN2hKSzVyPUOyMlkyOjlizszN M3jHd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
Calu-6 MkHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnYeHNJUUN3ME2zNk41PzR3IN88US=> NHntW|c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LOUCY MlnXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTN{LkGyOVMh|ryP MnfXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
SK-N-FI M{jmVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fJcGlEPTB;M{GuO|U{PSEQvF2= NEDveZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
SIG-M5 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEL3XpRKSzVyPUOxMlY5OzNizszN MoDYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NKM-1 M3X3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXf5RZF6UUN3ME2zNU4yOzl5IN88US=> NHHIUnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-SNU-1 NV:xNWR7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2Xk[2lEPTB;M{GuNVA2QSEQvF2= M2nxXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-H82 M4f5Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX\JR|UxRTNzLkCxN|Uh|ryP MmLqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H510A NHXNNYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXPQPXQzUUN3ME2zNE4xOzJ7IN88US=> M4GzZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ES3 NVmyOVBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXYZYNKSzVyPUK5Mlk2QDJizszN MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
BB30-HNC M{nLVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3LCfGlEPTB;MkmuPVQ5OyEQvF2= Mm\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
KM12 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlT4TWM2OD1{OT62NlM6KM7:TR?= M13XVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
GI-1 NUS1XXIxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2TxVWlEPTB;MkmuNFEyOyEQvF2= MknWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NOS-1 M4fscmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mny1TWM2OD1{OD65O|M{KM7:TR?= NFLMSGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
TE-8 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGfaS3RKSzVyPUK4MlkxQCEQvF2= NGTqZ5Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
TE-9 NWXhSG9PT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG[3VnJKSzVyPUK4Mlc6PjlizszN NHLvU289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
HL-60 NV76cJp6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTJ5Lkm4Olkh|ryP MlrpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
QIMR-WIL MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\keHNKSzVyPUK3MlkyPDRizszN NVjtW3RGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KARPAS-299 NX7FcpJlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPvXmR6UUN3ME2yOk45PjR4IN88US=> M2jDVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
KURAMOCHI NVr3blV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVPXdJdkUUN3ME2yOk45ODh{IN88US=> M33xflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BL-41 NYrVO5RDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVzjfnZvUUN3ME2yOU46PTl5IN88US=> Mlz2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H2126 MljTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYC2eHY{UUN3ME2yOU43PTJ7IN88US=> NYHDV41DRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
HOP-62 NFuyR4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXryR2xlUUN3ME2yOU41PDJ3IN88US=> NF;0Vow9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
IST-SL2 NFHLe29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTJ2LkWzOFMh|ryP NETsPGE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
HH M2O2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTJ2LkO4NVkh|ryP NFm5XFE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LS-513 Mk\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXHTWM2OD1{Mz61NVc6KM7:TR?= MojPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
EB-3 M3zFeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVvJR|UxRTJ|LkG4N|Eh|ryP NILWclU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
ACN NGC3RpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXPJR|UxRTJzLkOzPFkh|ryP NEfoeZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NOMO-1 M{Dpemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfQ[XBKSzVyPUKxMlIxODhizszN MnjxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
ES8 NH7ldFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVPJR|UxRTJzLkC2JO69VQ>? MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
CESS Mmi0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7Ucmw{UUN3ME2yNE45PTR7IN88US=> MlLtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
BL-70 MofiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWfBd3B1UUN3ME2yNE4{Ojd2IN88US=> M2HuTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MHH-PREB-1 NVvtTm5VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGf2VodKSzVyPUKwMlA{PTZizszN NITrNJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
BC-1 NVnEfppvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MULJR|UxRTF7LkGxPVgh|ryP M4P5WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LC4-1 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mm\sTWM2OD1zOD64O|M1KM7:TR?= Mmm3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
COLO-320-HSR MmLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHfteGJKSzVyPUG4Mlc3QDhizszN NV7tOJlQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
A101D Mny2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlHSTWM2OD1zOD6zNlA5KM7:TR?= MlfKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
BC-3 MkO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jHRWlEPTB;MUiuNFMxPSEQvF2= NWfEPYNNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TGW NF\KSmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljlTWM2OD1zNz64NVI1KM7:TR?= NGPNeY09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
JAR MlXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jqT2lEPTB;MUeuNFE2OiEQvF2= MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HD-MY-Z M1r6PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXXnc5loUUN3ME2xOk45OjR4IN88US=> MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H1304 NXTISmY4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TBbmlEPTB;MU[uN|YxOSEQvF2= NHX6OmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
OS-RC-2 M1PQd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXnMR|dEUUN3ME2xOU45Ozh{IN88US=> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
OCI-AML2 Ml65S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XXWGlEPTB;MUWuOlQ5OiEQvF2= MkfWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HCC1599 NVu3TIZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUPJR|UxRTF2LkW5O|Uh|ryP M{jjdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SCC-3 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUP0UplSUUN3ME2xOE4zQTV4IN88US=> M4DOfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
RPMI-6666 M2DERWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mnn6TWM2OD1zMz65NVIyKM7:TR?= MlTzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
MEG-01 NHXwVHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmfDTWM2OD1zMz64N|c6KM7:TR?= NGP3fHY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
Raji MonyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPZU|JKSzVyPUGzMlc5QTRizszN MoXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
RPMI-8402 NGjsfJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTF|Lk[yOlIh|ryP MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
GCIY NILJdJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV\u[lZiUUN3ME2xNk45PjF|IN88US=> M4jCdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
697 NF\YNWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn25TWM2OD1zMj62NFA4KM7:TR?= Mlv6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
D-247MG M{S1c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3zOUWlEPTB;MUKuN|UyPiEQvF2= NUTmVopwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NB1 NV\UVm1lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkOxTWM2OD1zMj6zN|A5KM7:TR?= MkDpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
COR-L279 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfNTWM2OD1zMj6yPVA4KM7:TR?= NYnDSGJERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
LB831-BLC MkHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\UeJU1UUN3ME2xNU42PjJ2IN88US=> NFi5ZWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
ST486 NUjxcZNsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljvTWM2OD1zMD6zOVEh|ryP MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
SK-UT-1 M3jsVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fsdmlEPTB;MUCuN|Uh|ryP MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
BB65-RCC NIC3V2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTlwOUe0PVUh|ryP MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KARPAS-422 MljqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIL2bYNKSzVyPUmuPVY{OzZizszN M2mxNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
Becker M3zhUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jzVGlEPTB;OT60OlA5OiEQvF2= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KS-1 NGTPSppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnwWYtIUUN3ME25MlQ2Pzh3IN88US=> NFqxd4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
JiyoyeP-2003 M4DWcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\PTWM2OD16LkWwNlY1KM7:TR?= NWL4VpEyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCCIT MnXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUT6elRFUUN3ME23MlU2PDh{IN88US=> NWPRb3poRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MRK-nu-1 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWPaT2lOUUN3ME23MlEzQTZ7IN88US=> NVjBWYVMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
A3-KAW NYDQTodoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIX6PHdKSzVyPUWuO|YyOTZizszN M{Lz[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SK-N-MC NUPSfIFDeUiWUzDhd5NigQ>? M2rESZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz NYrtXFFpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
LP-1 MVLBdI9xfG:|aYOgZZN{[Xl? NGT2NpA{OCC3TR?= MVezJIhzew>? NF\1ZotKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIFzQMVEh[2WubIOgZZQhOzBidV2gZYZ1\XJiMzDodpMhfXOrbnegWHVPTUxic4ThbY5qdmdiYomg[oxwfyCleYTvcYV1enl? NX;vUVUxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
LP-1 MmXWR5l1d3SxeHnjbZR6KGG|c3H5 M4m0VFIxKHSxIEOwJJVO MYGyOEBpenN? NF:4cpFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBNWC1zIHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBk\WyuII\pZYJqdGm2eTDheEAzOCC2bzCzNEB2VSC2cnXheIVlKG[xcjCyOEBpenNiZn;scI94\WRiYomge4F{cG:3dDDt[YF{fXKnZDDh[pRmeiC2b4ThcEA4OiCqcoOg[5Jwf3SqIIDldolw\CCjbHHtZZIh[my3ZTDhd5NigSC{ZXzheIl3\SC2bzDjc451em:u NH\yWVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
LP-1 MWHBdI9xfG:|aYOgZZN{[Xl? MkW5N|AhfU1? NYfTdJZXOS53IHjydy=> NWX5dWh4UW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDMVE0yKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
LP-1 NYXEVnVGSXCxcITvd4l{KGG|c3H5 NFrhS3Q{OCC3TR?= M4\SS|MhcHK| NGTQdHlKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIFzQMVEh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKG:oIF3jcE0yKHC{b4TlbY4hdGW4ZXygZZQhOzBidV2gZYZ1\XJiMzDodpMh[nliaX3teY5w[myxdITpcoc> M37tVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
LP-1 NX7DZ4hqSXCxcITvd4l{KGG|c3H5 MlP4N|AhfU1? MW[zJJRwKDViaILz M4\LVGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTGCtNUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCuZY\lcEBw\iClbHXheoVlKFCDUmCgZZQhOzBidV2gZYZ1\XJiMzD0c{A2KGi{czDifUBqdW23bn;icI91fGmwZx?= NYLuTVZIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 MW\BdI9xfG:|aYOgZZN{[Xl? MkDhN|AhfU1? MmnvOUBpenN? NY\ERnh5UW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBt\X[nbDDv[kBkdGWjdnXkJHBCWlBiYYSgN|AhfU1iYX\0[ZIhPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 MXfBdI9xfG:|aYOgZZN{[Xl? MXWzNEB2VQ>? M1TaT|EvPSCqcoO= NHHp[mtKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IH\hd5Qhe2yxdzDtbYdz[XSrbnegbJlx\XKyaH;zdIhwenmuYYTl[EBTVkFicH;sfY1memG|ZTCyU{Bnd3KvIHH0JFMxKHWPIHHmeIVzKDFwNTDodpMh[nliaX3teY5w[myxdITpcoc> NUi0RYNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
RPM18226 M3nqRmFxd3C2b4Ppd{Bie3OjeR?= M3vsXFMxKHWP M4\EeFEvPSCqcoO= Mm\MTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCUUF2xPFIzPiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gVm5CKHCxbInt[ZJie2ViMjDwbI9{eGixc3XybY5mKDJibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgNU42KGi{czDifUBqdW23bn;icI91fGmwZx?= NFjLNXg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
RPM18226 M1K0d2Fxd3C2b4Ppd{Bie3OjeR?= NIixS28{OCC3TR?= NYfJbnNNOyCqcoO= MlLFTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCUUF2xPFIzPiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gUYNtNTFicILveIVqdiCuZY\lcEBifCB|MDD1UUBi\nSncjCzJIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? MmTNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
RPM18226 NFK2R|dCeG:ydH;zbZMh[XO|YYm= M1zhTFMxKHWP NGPVNHU{KHSxIEWgbJJ{ NYTHb45sUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDSVG0yQDJ{NjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBt\X[nbDDv[kBkdGWjdnXkJHBCWlBiYYSgN|AhfU1iYX\0[ZIhOyC2bzC1JIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? Mny3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 MVnBdI9xfG:|aYOgZZN{[Xl? NVPNNlROOzBidV2= M3;POFMhcHK| M4TpSGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDYTWFRKHC{b4TlbY4hdGW4ZXygZZQhOzBidV2gZYZ1\XJiMzDodpMh[nliaX3teY5w[myxdITpcoc> Mn7uQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NUL2So5{SXCxcITvd4l{KGG|c3H5 MlfPN|AhfU1? NWfJdGNXOyCqcoO= M4nycGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDzeZJ3cX[rbjDwdo91\WmwIHzleoVtKGG2IEOwJJVOKGGodHXyJFMhcHK|IHL5JIludXWwb3Lsc5R1cW6p M1XSbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
RPM18226 NHvnPXFCeG:ydH;zbZMh[XO|YYm= MonzN|AhfU1? NEK2W2k{KGi{cx?= M1\qXWlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iUmDNNVgzOjZiY3XscJMh[XRiM{CgeW0h[W[2ZYKgN{BpenNidYPpcochXFWQRVygd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= NHKwSYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
NCI-H929 MnvvRZBweHSxc3nzJIF{e2G7 M{exVVMxKHWP MnezNU42KGi{cx?= MWfJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p Ml2yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NID6NVNCeG:ydH;zbZMh[XO|YYm= MYCzNEB2VQ>? Mkf3NU42KGi{cx?= MXTJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KGSncHjvd5Bpd3K7bHH0bY9vKG:oIIDSZkBifCCVMkS5M3QzPTJiYYSgN|AhfU1iYX\0[ZIhOS53IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NGHIPXVEgXSxdH;4bYNqfHliYYPzZZk> MV:yNEB1dyB|MDD1US=> NX7wZ2NTOTZiaILz MmHOR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUmNKNUh7MkmgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKGOnbHygeoli[mmuaYT5JIF1KDJyIITvJFMxKHWPIITy[YF1\WRiZn;yJFE3KGi{czDmc4xtd3enZDDifUB4[XOqb4X0JI1m[XO3cnXkJIFnfGW{IITveIFtKDd{IHjyd{Boem:5dHigdIVzcW:mIHHsZY1ieiCkbIXlJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3y= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NFH6b4ZCeG:ydH;zbZMh[XO|YYm= M{myd|MxKHWP NEDkVFg{KGi{cx?= M{T5RWlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJG1kdC1zIIDyc5RmcW5ibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgN{BpenNiYomgbY1ufW6xYnzveJRqdmd? MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 Ml\pRZBweHSxc3nzJIF{e2G7 NVTHNmJ6OzBidV2= NVzxTGczOyCqcoO= Mn;JTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyClaHHu[4V{KGmwIFLjcE0zKHC{b4TlbY4hdGW4ZXygZZQhOzBidV2gZYZ1\XJiMzDodpMh[nliaX3teY5w[myxdITpcoc> MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 M3nuNGFxd3C2b4Ppd{Bie3OjeR?= NITHb|Y{OCC3TR?= M3L3[|MhcHK| MmHFTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{BifCB|MDD1UUBi\nSncjCzJIhzeyC3c3nu[{BVXU6HTDDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= NYToPZNqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 MYnBdI9xfG:|aYOgZZN{[Xl? MkTSN|AhfU1? NX7NOW9GOS53IHjydy=> Ml[2TY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gVm5CKHCxbInt[ZJie2ViMjDwbI9{eGixc3XybY5mKDVibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgNU42KGi{czDifUBqdW23bn;icI91fGmwZx?= NUC5OmRyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 M3ra[mFxd3C2b4Ppd{Bie3OjeR?= NWOyXm5YOzBidV2= NX\LUZd6OS53IHjydy=> NEfmepVKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBJ\G1{IHzleoVtKGG2IEOwJJVOKGGodHXyJFEvPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= M3v0bVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 NWfWRlY3SXCxcITvd4l{KGG|c3H5 MnXFN|AhfU1? MVixMlUhcHK| NXq5cZdNUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDv[kBxPTNiYXPjeY12dGG2aX;uJIF1KDNyIIXNJIFnfGW{IEGuOUBpenNiYomgbY1ufW6xYnzveJRqdmd? MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
SK-N-MC M2DCWpFJXFNiYYPzZZk> M3jBT5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz MmnxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOEC3NFMoRjJzMEiwO|A{RC:jPh?=
HCT116 NWW4b5NkTnWwY4Tpc44h[XO|YYm= MlTWN|AhfG9iNECgeY1wdC:O MX:yOEBpenN? NInU[VRKdmirYnn0bY9vKG:oIHP5Z4xqdiCDIHnuJIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDwdo91\WmwIHzleoVtKGG2IEOwJJRwKDRyIIXtc4wwVCCjZoTldkAzPCCqcoOgZpkhcW2vdX7vZoxwfHSrbnegZY5idHm|aYO= MmWxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOEC3NFMoRjJzMEiwO|A{RC:jPh?=
HCT116 M2CyOWZ2dmO2aX;uJIF{e2G7 M{HWfFMxKHSxIESwJJVud2xxTB?= M1rYWFI1KGi{cx?= NGniTGxKdmirYnn0bY9vKG:oIHP5Z4xqdiCEIHnuJIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDwdo91\WmwIHzleoVtKGG2IEOwJJRwKDRyIIXtc4wwVCCjZoTldkAzPCCqcoOgZpkhcW2vdX7vZoxwfHSrbnegZY5idHm|aYO= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HCT116 NIDKNGdHfW6ldHnvckBie3OjeR?= MmS3N|AhfG9iNECgeY1wdC:O MnXlNlQhcHK| MX;Jcohq[mm2aX;uJI9nKGO7Y3zpckBFOSCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5icILveIVqdiCuZY\lcEBifCB|MDD0c{A1OCC3bX;sM2wh[W[2ZYKgNlQhcHK|IHL5JIludXWwb3Lsc5R1cW6pIHHuZYx6e2m| M1rZeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEiwO|A{Lz5{MUC4NFcxOzxxYU6=
HCT116 NUD3RZJxTnWwY4Tpc44h[XO|YYm= MXqzNEB1dyB2MDD1cY9tN0x? MXmyOEBpenN? NUS5V|UzUW6qaXLpeIlwdiCxZjDDSGszKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCycn;0[YlvKGyndnXsJIF1KDNyIITvJFQxKHWvb3yvUEBi\nSncjCyOEBpenNiYomgbY1ufW6xYnzveJRqdmdiYX7hcJl{cXN? NGDZclg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HT-29 MknNSpVv[3Srb36gZZN{[Xl? MWqyMlUhfG9iNECgeW0> MVuyOEBpenN? M4\wS2lvcGmkaYTpc44hd2ZicnX0bY5w[myjc4TvcYEheHKxdHXpckBqdiCqdX3hckBJXC1{OTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4Yh[3mlbHnuJGEhdGW4ZXygZZQhOi53IITvJFQxKHWPIHHmeIVzKDJ2IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> NXHZUIF2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 NVHoXnYxS2WubDDjfYNt\SCjc4PhfS=> M3TKelI1KGi{cx?= NYH6OI13S2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{KvUUBxcGG|ZTDh[pRmeiB{NDDodpMhfXOrbnegdJJweGmmaYXtJIlw\GmmZTDhcoQhSnKmVTDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= M1PZT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
RPMI8226 NYL4[nJpS2WubDDjfYNt\SCjc4PhfS=> NYj2[mx7OjRiaILz MoPYR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gVnBOUTh{Mk[gZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKGG2IFeyM20heGijc3WgZYZ1\XJiMkSgbJJ{KHW|aX7nJJBzd3CrZHn1cUBqd2SrZHWgZY5lKEK{ZGWgd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= NHzBO5g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
MCF7 MX3D[YxtKGO7Y3zlJIF{e2G7 M3;veFI1KGi{cx?= NIDKXJNE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBOS0Z5IHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJHMheGijc3WgZ4VtdCCyb4D1cIF1cW:wIHHmeIVzKDJ2IHjyd{B2e2mwZzDwdo9xcWSrdX2gbY9lcWSnIHHu[EBDemSXIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 NXX1Sm45RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 NEHpRpVE\WyuIHP5Z4xmKGG|c3H5 MYqyOEBpenN? NFzP[JBE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBOS0Z5IHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCC|dXKtS|EheGijc3WgZYZ1\XJiMkSgbJJ{KHW|aX7nJJBzd3CrZHn1cUBqd2SrZHWgZY5lKEK{ZGWgd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= NIXFSpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
RPMI8226 MmP2R4VtdCCleXPs[UBie3OjeR?= M4DC[VI1KGi{cx?= M3jhZ2NmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJHJRVUl6MkK2JINmdGy|IHHzd4V{e2WmIHHzJIFk[3WvdXzheIlwdiCjdDDzeYIuTzFicHjhd4Uh[W[2ZYKgNlQhcHK|IIXzbY5oKHC{b4Dp[Il2dSCrb3Tp[IUh[W6mIFLy[HUhe3SjaX7pcoch[nliZnzve{BkgXSxbXX0dpk> NIPpNm89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
MCF7 NEnVPHFE\WyuIHP5Z4xmKGG|c3H5 NWjzbnd[QDBidV2= MlHENlQhcHK| MnvnR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gZYN1cX[nbImgdoVxdGmlYYTpcochTE6DIHzleoVtKGG2IEiwJJVOKGGodHXyJFI1KGi{czD1d4lv\yCycn;wbYRqfW1iaX;kbYRmKGGwZDDCdoRWKHO2YXnubY5oKGK7IH\sc5ch[3m2b33leJJ6 MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 NFT6eYxHfW6ldHnvckBie3OjeR?= MV6yNEB2VQ>? NGHCXmYzPCCqcoO= MkfFTY5lfWO2aX;uJI9nKHB3Mz3k[ZBmdmSnboSgeJJidnOlcnnweIlwdmGuIHHjeIl3cXS7IHnuJIh2dWGwIF3DSlch[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4Uhd2ZicEKxJHdCTjFibHX2[Ywh[XRiMkCgeW0h[W[2ZYKgNlQhcHK|IHL5JIludXWwb3\seY9z\XOlZX7j[UBie3OjeR?= MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
RPMI8226 MkHVR4VtdCCleXPs[UBie3OjeR?= NILnWYkzPCCqcoO= NU\RPXhYS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWlCPSUiyNlYh[2WubIOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5iUzDwbIF{\SClZXzsJJBweHWuYYTpc44h[W[2ZYKgNlQhcHK|IIXzbY5oKHC{b4Dp[Il2dSCrb3Tp[IUh[W6mIFLy[HUhe3SjaX7pcoch[nliZnzve{BkgXSxbXX0dpk> NIHLUmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
RPMI8226 NIX6XWhE\WyuIHP5Z4xmKGG|c3H5 MVq4NEB2VQ>? NIi0dVAzPCCqcoO= NEDuPGVE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBTWE2LOEKyOkBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hd2ZiYXP0bZZmdHlicnXwcIlk[XSrbnegSG5CKGyndnXsJIF1KDhyIIXNJIFnfGW{IEK0JIhzeyC3c3nu[{Bxem:yaXTpeY0hcW:maXTlJIFv\CCEcnTVJJN1[WmwaX7nJIJ6KG[ub4egZ5l1d22ndIL5 M3nJXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
A549 NHnzNXhCeG:ydH;zbZMh[XO|YYm= MX[yJJVO MmnBOFghcHK| MkjHTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCDNUS5JINmdGy|IHHzd4V{e2WmIHHzJGRPSSCocnHncYVvfGG2aX;uJIF1KDJidV2gZYZ1\XJiNEigbJJ{KGK7IHHnZZJwe2ViZ3XsJIVt\WO2cn;wbI9z\XOrcx?= NInkelM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[yN|Q6OSd-MkO2NlM1QTF:L3G+
Sf9 MW\GeY5kfGmxbjDhd5NigQ>? MV2xNEBucW6| NIHxWXNKdmirYnn0bY9vKG:oIFjpd{03NXSjZ3fl[EBz\WOxbXLpcoFvfCCqdX3hckBETEt{L3P5Z4xqdkViZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{NWmwZnXjeIVlKHOoOTDj[YxteyC3c3nu[{BpcXO2b37lJGgyKGG|IIP1ZpN1emG2ZTDh[pRmeiBzMDDtbY5{KGK7IHzpdZVq\CC|Y3nueIltdGG2aX;uJINwfW62aX7nJIlvKHC{ZYPlcoNmKG:oIGvnZY1u[S1|MmDdRXRRNCCLQ{WwJF0hOC5zIN88UU4> NETSTIE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NESxO|U3Pid-MkS0NVc2PjZ:L3G+
BJ MlnYSpVv[3Srb36gZZN{[Xl? MYGxNEB2VQ>? MXixNEBl[Xm| NFnIU4NUfXCycnXzd4lwdiCxZjDz[Y5me2OnbnPlJIlvKGi3bXHuJGJLKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHPlcIwhdnWvYnXyJIF1KDFyIIXNJIFnfGW{IEGwJIRigXNiYomgd4Vv\XOlZX7j[UBz\X[ncoPhcEBie3OjeR?= MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6MUm4Okc,OjR4OEG5PFY9N2F-
BJ NUC5UGd7TnWwY4Tpc44h[XO|YYm= MX6xNEB2VQ>? NFTuXHgyOCCmYYnz MYHJcohq[mm2aX;uJI9nKGG2YYjpZUB1\Wyjbnfp[YN1[XOrYT3teZRifGWmIHnuJIh2dWGwIFLKJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGOnbHygcpVu[mW{IHH0JFExKHWPIHHmeIVzKDFyIHThfZMh[nlic3Xu[ZNk\W6lZTDy[ZZmenOjbDDhd5NigQ>? NFnsRVc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4NVk5Pid-MkS2PFE6QDZ:L3G+
MCF7 Mlv3SpVv[3Srb36gZZN{[Xl? NG\XVGMyOCC3TR?= M2Sw[|ExKG2rboO= MYDT[Y5{cXSrenH0bY9vKG:oIHnu[pJiemWmLXnu[JVk\WRiRF7BJIRidWGpZTDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDjc4xwdnliZn;ycYF1cW:wIHH0JFExKHWPIIDy[ZRz\WG2ZXSg[o9zKDFyIH3pcpMh\m:ubH;3[YQh[nliaYLyZYRq[XSrb36g[o9zKDRiaILzJI1m[XO3cnXkJIFnfGW{IEGwJIRigXNiYomgZ5J6e3SjbDD2bY9t\XRic4ThbY5qdmdiYX7hcJl{cXN? NFHjZXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nki1NVUxPSd-Mk[4OVE2ODV:L3G+
Caco2 MlLhR4VtdCCleXPs[UBie3OjeR?= MV;D[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDDZYNwOiClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzFxUzDwbIF{\SCkeTDIc4VkcHO2IIP0ZYlvcW6pIHLhd4VlKG[udX;y[ZNk\W6lZTDhd5NigQ>? NY\XTZBURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyNVQzOzFpPkK4NlE1OjNzPD;hQi=>
HaCaT MoXpR4VtdCCleXPs[UBie3OjeR?= NGG3NW1E\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBJ[UOjVDDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{GvV{BxcGG|ZTDifUBJd2WlaIP0JJN1[WmwaX7nJIJie2WmIH\seY9z\XOlZX7j[UBie3OjeR?= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJzNEKzNUc,Ojh{MUSyN|E9N2F-
HuH7 NXv2T3JYS2WubDDjfYNt\SCjc4PhfS=> MlLoR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gTJVJPyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzFxUzDwbIF{\SCkeTDIc4VkcHO2IIP0ZYlvcW6pIHLhd4VlKG[udX;y[ZNk\W6lZTDhd5NigQ>? MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJzNEKzNUc,Ojh{MUSyN|E9N2F-
PC3 M{LOemNmdGxiY4njcIUh[XO|YYm= MYTD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDQR|Mh[2WubIOgZZN{\XO|ZXSgZZMh[WOldX31cIF1cW:wIHH0JGczN01icHjhd4Uh[nliSH;lZ4h{fCC|dHHpcolv\yCkYYPl[EBndHWxcnXzZ4Vv[2ViYYPzZZk> NEjBbZM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
MDA-MB-231 NGG2S3pE\WyuIHP5Z4xmKGG|c3H5 NHO3cJpE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIF{e2W|c3XkJIF{KGGlY4XteYxifGmxbjDheEBIOS:VIIDoZZNmKGK7IFjv[YNpe3Ric4ThbY5qdmdiYnHz[YQh\my3b4Lld4NmdmOnIHHzd4F6 NX3xTGViRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyNVQzOzFpPkK4NlE1OjNzPD;hQi=>
HCT116 MWjD[YxtKGO7Y3zlJIF{e2G7 MnXCR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMT;TJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 M3;LWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MkG0NlMyLz5{OEKxOFI{OTxxYU6=
SK-N-MC M3WyZZFJXFNiYYPzZZk> NV;RWVNEeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDV3N{SzNEc,Ojh3NUe0N|A9N2F-
A673 M3nsO5FJXFNiYYPzZZk> MnP5dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? M4PReFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
DAOY MnPQdWhVWyCjc4PhfS=> MmewdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? NV3hfVBXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 NXrrd45TeUiWUzDhd5NigQ>? MkLRdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUO3JINmdGy| NXnxe4hPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SJ-GBM2 NUHENlJoeUiWUzDhd5NigQ>? MU\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= NE\mXGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
LAN-5 M3XGS5FJXFNiYYPzZZk> MnG1dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEyDTj21JINmdGy| M3fqWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-MC NF3p[G5yUFSVIHHzd4F6 NYjKbYFMeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NVe0S4NORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxPVk4ODJpPkOwNVk6PzB{PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-Rb / p-CDK2 / CDK2 / Cyclin D1 / Cyclin A2 / ERα / ERβ/ AIB1 / PELP1 ; 

PubMed: 21834972     


(a) The model cells MCF7, MCF7-TamR, MCF7-HER2, and MCF7-LTLTca were treated with roscovitine and the status of cell cycle regulators and the estrogen receptor (ERα) signaling proteins was analyzed by western blotting. 

pT231-tau / pS202-tau / tau; 

PubMed: 30915013     


SH-SY5Y-(P301L) cells were exposed for 6 h to a range of roscovitine concentrations. Cells were harvested and proteins were resolved by SDS-PAGE followed by western blotting.

21834972 30915013
Immunofluorescence
E2F1 / FASN / Bmi1 / Cyclin D2 / CDK2 / CDK4 ; 

PubMed: 20890301     


Immunofluorescence analysis of E2F1, FASN, E2F1/Shh target Bmi1, cyclin D2, cdk 2, and cdk 4 in Pzp53med cells treated with DMSO (control) or the cdk inhibitor roscovitine (10 nM) for 18 hours.

CDK1 / Smek2 / FUBP1 / Cdc20 ; 

PubMed: 24534090     


A-D Validation of changes in chromatin affinity following Cdk inhibition of indicated candidates (2 h, 50 μM roscovitine) using Triton extraction and immunofluorescence (IF) in HeLa cells. Quantification of IF data was performed by measuring changes in signal intensities in Image J.

20890301 24534090
Growth inhibition assay
Cell viability; 

PubMed: 29996940     


Cell viability assay on OVCAR5, OAW42, SKOV3 and NL3507 cells treated with roscovitine (2, 5, 10, 20, 40 μM) up to 96 h. Each point represents the mean of three replicates. Error bars, SD

29996940
In vivo Roscovitine, at a dose of 50 mg/kg, significantly inhibits growth of The Ewing's sarcoma family of tumors (ESFT) xenografts. [4] Roscovitine enhances the antitumor effect of doxorubicin without increased toxicity with a mechanism that involves cell cycle arrest rather than apoptosis in nude mice bearing established MCF7 xenografts. [5]

Protocol

Kinase Assay:[1]
- Collapse

Enzymes :

Kinases activities are assayed at 30 °C in buffer C. Blank values are subtracted from the data and activities calculated as molar amount of phosphate incorporated in protein acceptor during a 10-minute incubation. Controls are performed with appropriate dilutions of DMSO. In a few cases, phosphorylation of the substrate is assessed by autoradiography after SDS/PAGE. p34cdc2/cyclin B is purified from M-phase starfish (M. glacialis) oocytes by affinity chromatography. It is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP (3000 Ci/mmol; 1 mCi/mL) in a final volume of 30 μL. After a 10-minute incubation at 30 °C, 25-μL aliquots of supernatant are spotted onto pieces of Whatman P81 phosphocellulose paper, and, after 20 seconds, the filters are washed five times (for at least 5 minutes each time) in a solution of 10mL phosphoric acid/L water. The wet filters are transferred into 6-mL plastic scintillation vials, 5 mL ACS scintillation fluid is added and the radioactivity measured in a Packard counter. The kinase activity is expressed as molar amount of phosphate incorporated in histone H1 during a 10-minutes incubation or as a percentage of maximal activity. p33cdk2/cyclin A and p33cdk2/cyclinE are reconstituted from extracts of sf9 insect cells infected with various baculoviruses. Cyclins A and E are fusion proteins with glutathione S-transferase and the complexes are purified on glutathione-agarose beads. Kinase activities are assayed with 1 mg/mL histone H1, in the presence of 15 μM [γ-32P]ATP, during 10 minutes, in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/p35 is purified from bovine brain, excluding the Mono S-chromatographic step. The active fractions from the Superose 12 column are pooled and concentrated to a final concentration of approximately 25 μg enzyme/mL. The kinase is assayed with 1 mg/mL histone HI in the presence of 15 μM [γ-32P]ATP, during 10 minutes in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/cyclin D1 is obtained from insect cell lysates. Cdk4 is a fusion protein with glutathione-S-transferase and the active complex is purified on glutathione-agarose beads. Its kinase activity is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. After a 15-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10 % SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. p33cdk4/cyclinD 2 is obtained from insect cell lysates. It is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. After a 30-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10% SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. MAP kinase erkl (tagged with glutathione-S-transferase), is expressed in bacteria, purified on glutathione-agarose beads and assayed with 1 mg myelin basic protein/ml in the presence of 15 μM [γ-32P]ATP as described above for the p34cdc2cyclin B kinase. His-tagged erkl and erk2 are activated in vitro by mitogen-activated protein kinase kinase, purified (Ni-affinity and Mono Q) and assayed as described above during 10 minutes in a final volume of 30 μL. Protein kinase C isoforms are purified from baculovirus infected sf9 insect cells and assayed with 1 mg/mL protamine sulfate in the presence of 15 μM [γ-32P]ATP, during 10 minutes at 30 °C, in a final volume of 30 μL. Phosphorylated protamine sulfate is recovered on Whatman P81 phosphocellulose paper as described for the cdc2 kinase. The catalytic subunit of cAMP-dependent protein kinase, purified from bovine heart, is assayed with 1 mg histone Hl/ml, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. cGMP-dependent protein kinase, purified to homogeneity from bovine tracheal smooth muscle, is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. Casein kinase 2 is isolated from rat liver cytosol and assayed with 1 mg casein/mL and 15 μM [γ-32P]ATP. The substrate is spotted on Whatmann 3MM filters and washed with 10% (mass/vol.) trichloroacetic acid. Myosin light chain kinase, purified from chicken gizzard is assayed in the presence of 100 nM calmodulin, 100 μM CaCl2, 50 mM Hepes, 5 mM MgCI,, 1 mM dithiothreitol and 0.1 mg BSA/ml at pH 7.5 using a synthetic peptide based on the smooth-muscle myosin light-chain phosphorylation site and in the presence of 15 μM [γ-32P]ATP, in a final volume of 50 μL. Incorporation of radioactive phosphate is monitored on phosphocellulose filters as described above. ASK-γ, a plant homologue of GSK-3, is expressed as a glutathione-S-transferase fusion protein in Escherichia coli and purified on glutathione-agarose. ASK-γ kinase is assayed, for 10 minutes at 30 °C, with 5 μg myelin basic protein, in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. The phosphorylated myelin basic protein is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. Insulin receptor tyrosine kinase domain (CIRK-41) is overexpressed in a baculovirus system and purified to homogeneity. Its kinase activity is assayed, for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. c-src kinase is purified from infected Sf9 cells. The v-abl kinase is expressed in E. coli and affinity purified on IgG Affigel 10. Both kinases are assayed for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase.
Cell Research:[1]
- Collapse
  • Cell lines: Leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer
  • Concentrations: 0.01 - 100 μM
  • Incubation Time: 48 hours
  • Method: 60 human tumour cell lines comprising nine tumor types are cultured for 24 hours prior to a 48-hour continuous exposure to 0.01-100 μM roscovitine. A sulforhodaminine B protein assay is used to estimate the cytotoxicity.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: A4573 cells are injected s.c. into the right posterior flank of CD1 nu/nu mice.
  • Dosages: ≤50 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 71 mg/mL (200.31 mM)
Water Insoluble
Ethanol '6 mg/mL
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+69% PEG 400
For best results, use promptly after mixing.
5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 354.45
Formula

C19H26N6O

CAS No. 186692-46-6
Storage powder
in solvent
Synonyms CYC202, R-roscovitine
Smiles CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How can I reconstitute the drug for in vivo studies?

  • Answer:

    S1153 in 1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+PEG 400 is a clear solution which is okay for injection. And S1153 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30mg/ml is a suspension, which is fine for oral gavage.

CDK Signaling Pathway Map

CDK Inhibitors with Unique Features

Related CDK Products

Tags: buy Roscovitine (Seliciclib) | Roscovitine (Seliciclib) supplier | purchase Roscovitine (Seliciclib) | Roscovitine (Seliciclib) cost | Roscovitine (Seliciclib) manufacturer | order Roscovitine (Seliciclib) | Roscovitine (Seliciclib) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID